{"title":"2022年临床药学大会","authors":"","doi":"10.1002/pnp.781","DOIUrl":null,"url":null,"abstract":"The Clinical Pharmacy Congress 2022 marked its 11th birthday, celebrating the return to normality after the pandemic with the delivery of over 250 educational sessions by industry experts over two days, to enhance the professional and personal development of attendees. Joy Ogden covers some highlights of the conference on thought‐provoking subjects such as risks of dementia with antimuscarinics and sessions on clinical priorities in epilepsy and headache.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":" ","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical Pharmacy Congress 2022\",\"authors\":\"\",\"doi\":\"10.1002/pnp.781\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The Clinical Pharmacy Congress 2022 marked its 11th birthday, celebrating the return to normality after the pandemic with the delivery of over 250 educational sessions by industry experts over two days, to enhance the professional and personal development of attendees. Joy Ogden covers some highlights of the conference on thought‐provoking subjects such as risks of dementia with antimuscarinics and sessions on clinical priorities in epilepsy and headache.\",\"PeriodicalId\":43913,\"journal\":{\"name\":\"Progress in Neurology and Psychiatry\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Progress in Neurology and Psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/pnp.781\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Neurology and Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pnp.781","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
The Clinical Pharmacy Congress 2022 marked its 11th birthday, celebrating the return to normality after the pandemic with the delivery of over 250 educational sessions by industry experts over two days, to enhance the professional and personal development of attendees. Joy Ogden covers some highlights of the conference on thought‐provoking subjects such as risks of dementia with antimuscarinics and sessions on clinical priorities in epilepsy and headache.
期刊介绍：
Progress in Neurology and Psychiatry is published nine times a year, and is a journal for specialists in secondary care, GPs with an interest in neurology and psychiatry, community psychiatric nurses and other specialist healthcare professionals. Articles cover management, news updates and opinion in all areas of neurology and psychiatry.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
